Value Bridge — HACKENSACK UNIVERSITY MEDICAL CENTER
Current $-50M → Target $-6M (+$44.1M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-50.3M
Current EBITDA
$-6.2M
Target EBITDA
+$44.1M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$10.0M
Payer Mix Optimization
$24.0M
Cost to Collect Reduction
$8.0M
Clean Claim Improvement
$6.0M
Volume & Rate Growth
$39.9M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-50M to $-6M. The highest-impact lever is Volume & Rate Growth at $16.0M probability-weighted.
IC talking point: "We see $44M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $485M in equity value creation."